As health insurance giants Cigna and Anthem seek regulatory approval for a controversial merger, they have been ramping up their spending on lobbying, enlisting an army of former government officials with ties to the key public officials who can influence the antitrust review process. The lobbying push comes as groups representing phyisicans and consumers have argued that the merger — which would create the largest private health insurance company in history — could raise premiums and limit medical care for more than 53 million people.
Featured News
DOJ Official Highlights Role of Antitrust and Intellectual Property in Driving US Innovation
Mar 26, 2026 by
CPI
US Judge Dismisses X Lawsuit Alleging Advertising Boycott
Mar 26, 2026 by
CPI
Congress Passes Bill to Unfreeze Billions in Small Business R&D Funding
Mar 26, 2026 by
CPI
EU Charges Major Adult Platforms Over Child Safety Failures Under Digital Services Act
Mar 26, 2026 by
CPI
European Regulators Target Snapchat Over Alleged Safety Failures
Mar 26, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Competitor Collaborations
Mar 26, 2026 by
CPI
Between Scylla and Charybdis – Navigating Transatlantic Antitrust Currents
Mar 26, 2026 by
Tilman Kuhn & Niklas Brüggemann
Cartel Enforcement Moves Into the Labor Market: Trends and Implications
Mar 26, 2026 by
Andreas Kafetzopoulos & Caroline Janssens
Rethinking Buy-Side Antitrust “Group Boycotts”
Mar 26, 2026 by
Craig Falls & Brendan McGuire
Positive Collaborations: The Tools Available to Competition Authorities to Encourage Beneficial Interactions Between Competitors
Mar 26, 2026 by
Rona Bar-Isaac & Thomas Withers